-
Barron's Picks And Pans: Pfizer's New Identity, Electric Vehicles, Hong Kong Exodus — And Is The Bull Market About To End?
Saturday, November 23, 2019 - 4:42pm | 649Read More...This weekend's Barron's cover story takes a look at Pfizer Inc. (NYSE: PFE) as it seeks to take a new direction. Other featured articles consider whether the bull run on Wall Street may end next year, and a look at the prospect of a major merger in financial services. Also, a look at an...
-
Analysts See Allergan Bid Of Over $180, Possibility of 'Hostile' Bid
Tuesday, May 20, 2014 - 4:19pm | 230Read More...Bernstein analyst Aaron Gal reported that Valeant Pharmaceuticals International's (NYSE: VRX) offer for Allergan (NYSE: AGN) should be in the $190.00 per share range. Gal reported that Valeant should offer $190.00 per share cash or an option of part of the deal in cash. The analyst added if...
-
When It Comes To Drug Stocks, Do Not Always Buy The News
Thursday, April 10, 2014 - 11:30am | 568Read More...When it comes to the bio-tech, pharma and therapeutic sectors, the results from drug trials and the results from FDA evaluations can make or break stocks. On many occasions, the percentage leader and loser boards are littered with companies from these sectors that either released positive or...
-
Idenix and Spectrum Pharmaceuticals to Open Near 52-Week Highs
Tuesday, November 22, 2011 - 7:49am | 364Read More...While the markets were down yesterday, news that Gilead Sciences (NASDAQ: GILD) would acquire Pharmasset (NASDAQ: VRUS) pushed some biotech stocks higher. Idenix Pharmaceuticals (NASDAQ: IDIX) and Spectrum Pharmaceuticals (NASDAQ: SPPI) reached new multiyear highs of $8.05 and $13.00 per share,...
-
Is it Too Late To Jump Into Johnson & Johnson (JNJ)?
Monday, September 20, 2010 - 8:00pm | 265Read More...Many analysts, including myself, have been touting Johnson & Johnson (NYSE: JNJ) as a high quality, dividend paying blue chip for the last several months. The company is top quality with very stable, predictable, cash flows and a solid 3.5% dividend yield. In addition the company has upped it'...
-
US Stocks Jump Up; Rally Driven By Health, Pharma Stocks (AXP, DD, MRK, PFE, MRK, THC, HMA)
Monday, March 22, 2010 - 3:48pm | 227Read More...US stocks have climbed today, driven the most by the healthcare sector. Healthcare stocks are rising as investors believe that the number of insured customers for hospitals and pharmaceutical firms may spike, with the passage of the reform bill. While the Dow Jones Industrial Average has jumped 47....
-
Pharma Stocks Dive On Missed Expectations
Wednesday, February 3, 2010 - 12:55pm | 255Read More...Pharma stocks headed south after a couple of top global drugmakers posted depressed results and announced lackluster forecasts today. Pfizer Inc (NYSE: PFE) and Roche Holding AG (VTX: ROG) announced disappointing figures. Pfizer, the world's largest drugmaker, projected its 2010 revenues between $...
